Decoding Sepsis: Rethinking How We Detect Critical Illness with Tim Sweeney, MD, PhD
About this episode
This episode explores how advances in AI and diagnostics can transform sepsis detection and improve patient outcomes.
Sepsis remains one of medicine's most difficult diagnostic challenges, where every hour can impact patient outcomes. In this episode of Innovate & Elevate, Sharon Kedar sits down with Dr. Tim Sweeney, Co-Founder and CEO of Inflammatix, to explore how advances in artificial intelligence, host-response diagnostics, and precision medicine could transform the way clinicians detect infection and critical illness. Dr. Sweeney shares the personal experience that launched his two-decade mission to improve sepsis care, explains why traditional diagnostic approaches often fall short, and discusses how Inflammatix's TriVerity™ platform is helping physicians identify the right patients for the right treatment at the right time. This Episode Is For You If: - You want to understand why sepsis remains one of healthcare's most challenging diagnoses. - You're interested in how artificial intelligence is being applied to real-world clinical decision-making. - You want to learn how innovation can improve outcomes for critically ill patients. Connect with Dr. Tim Sweeney: - LinkedIn: https://linkedin.com/in/tim-sweeney-a6589594/ - X: https://x.com/timsweeney83 - Inflammatix…
More episodes of Innovate and Elevate
Explore listener stats, chart rankings, contacts and more on the Innovate and Elevate podcast page.